These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Tissue renin-angiotensin system: a site of drug action? Zimmerman BG; Dunham EW Annu Rev Pharmacol Toxicol; 1997; 37():53-69. PubMed ID: 9131246 [TBL] [Abstract][Full Text] [Related]
6. Prorenin anno 2008. Danser AH; Batenburg WW; van Esch JH; Krop M J Mol Med (Berl); 2008 Jun; 86(6):655-8. PubMed ID: 18322669 [TBL] [Abstract][Full Text] [Related]
8. Is there a local renin-angiotensin system in the heart? Danser AH; Saris JJ; Schuijt MP; van Kats JP Cardiovasc Res; 1999 Nov; 44(2):252-65. PubMed ID: 10690302 [TBL] [Abstract][Full Text] [Related]
9. Second Björn Folkow Award Lecture. The renin-angiotensin system: new surprises ahead. Schalekamp MA J Hypertens Suppl; 1991 Dec; 9(6):S10-7. PubMed ID: 1818898 [TBL] [Abstract][Full Text] [Related]
10. Renin and prorenin disappearance in humans post-nephrectomy: evidence for binding? Krop M; de Bruyn JH; Derkx FH; Danser AH Front Biosci; 2008 May; 13():3931-9. PubMed ID: 18508487 [TBL] [Abstract][Full Text] [Related]
11. The (pro)renin receptor: a new addition to the renin-angiotensin system? Batenburg WW; Jan Danser AH Eur J Pharmacol; 2008 May; 585(2-3):320-4. PubMed ID: 18417113 [TBL] [Abstract][Full Text] [Related]
12. Characterization of angiotensin peptides in plasma of anephric man. Campbell DJ; Kladis A; Skinner SL; Whitworth JA J Hypertens; 1991 Mar; 9(3):265-74. PubMed ID: 1851790 [TBL] [Abstract][Full Text] [Related]
13. [Pharmacology of the renin-angiotensin system]. Kim S; Yammamoto K Nihon Yakurigaku Zasshi; 1994 Oct; 104(4):275-84. PubMed ID: 7959418 [TBL] [Abstract][Full Text] [Related]
14. Regulation of intrarenal and circulating renin-angiotensin systems in severe heart failure in the rat. Schunkert H; Tang SS; Litwin SE; Diamant D; Riegger G; Dzau VJ; Ingelfinger JR Cardiovasc Res; 1993 May; 27(5):731-5. PubMed ID: 8348571 [TBL] [Abstract][Full Text] [Related]
17. Beta-adrenergic receptor blockade as a therapeutic approach for suppressing the renin-angiotensin-aldosterone system in normotensive and hypertensive subjects. Blumenfeld JD; Sealey JE; Mann SJ; Bragat A; Marion R; Pecker MS; Sotelo J; August P; Pickering TG; Laragh JH Am J Hypertens; 1999 May; 12(5):451-9. PubMed ID: 10342782 [TBL] [Abstract][Full Text] [Related]